journal articlereview
oaidoi:10.1016/j.ccr.2010.11.028

The Ids Have It

Authors
Publication date
14 December 2010
Publisher
Elsevier Inc.
Doi

    Abstract

    In this issue of Cancer Cell, Anido et al. demonstrate that Id1 is the likely arbiter of divergent transforming growth factor-β (TGF-β) signaling in glioma-initiating cells (GICs) from different tumors. These findings hold both the promise and potential peril of therapeutic targeting of the TGF-β pathway

    Similar works

    Full text

    thumbnail-image

    Elsevier - Publisher Connector

    redirect
    oaidoi:10.1016/j.ccr.2010.11.028
    Last time updated on 05/05/2017

    This paper was published in Elsevier - Publisher Connector .

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.